Back to mobile site

Jefferies Assumes Compugen (CGEN) at Buy (Earlier)

October 14, 2020 9:51 AM EDT Send to a Friend
Jefferies analyst Chris Howerton assumes coverage on Compugen (NASDAQ: CGEN) with a Buy rating and a price target of $25.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login